Literature DB >> 20661083

Biomarkers are here to stay for clinical research and standard care.

Paul A Bunn, Fred R Hirsch, Robert C Doebele, D Ross Camidge, Marileila Varella-Garcia, Wilbur Franklin.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20661083     DOI： 10.1097/JTO.0b013e3181e7616e

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  3 in total

Review 1.  Acquisition and processing of endobronchial ultrasound-guided transbronchial needle aspiration specimens in the era of targeted lung cancer chemotherapy.

Authors:  William Bulman; Anjali Saqi; Charles A Powell
Journal:  Am J Respir Crit Care Med       Date:  2011-10-27       Impact factor: 21.405

2.  Rebiopsy during disease progression in patients treated by TKI for oncogene-addicted NSCLC.

Authors:  Cecile Bosc; Gilbert R Ferretti; Jacques Cadranel; Clarisse Audigier-Valette; Benjamin Besse; Fabrice Barlesi; Chantal Decroisette; Sylvie Lantuejoul; François Arbib; Denis Moro-Sibilot
Journal:  Target Oncol       Date:  2014-08-15       Impact factor: 4.493

3.  Personalized Combined Modality Therapy for Locally Advanced Non-small Cell Lung Cancer.

Authors:  D Nathan Kim; Taek-Keun Nam; Kevin S Choe; Hak Choy
Journal:  Cancer Res Treat       Date:  2012-06-30       Impact factor: 4.679
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.